Financial advisers

This website is for financial advisers, intermediaries and professional investors looking for all major asset classes and regions, with options for clients seeking growth, income or additional diversification through our range of funds.

Please select your country of residence*:
(*country of residence if an individual or country of operation if a corporation)

Please read the legal and regulatory terms and conditions that apply when using this website. By entering, you are confirming you are a 'financial adviser', accepting the terms and conditions of use.

Rathbone SICAV Multi-Asset Enhanced Growth Portfolio

Select other funds

  • Consistently outperformed return target
  • Track record of preserving capital - evidenced by low drawdowns
  • Unique approach to targeted-risk investing
  • Simple to understand and transparent investment strategy
  • Focus on future correlations and liquidity risk, not volatility
  • Low Ongoing Charges Figure (OCF) for truly active management
  • The strategy benefits from extensive experience, continuity and accountability
Costs and charges

MiFID II charges

L Acc GBP, L Acc EUR

Ongoing charges figure (OCF)
1.24%

Transaction costs
0.13%

Total MiFID II charges
1.37%

L0 Acc GBP

Ongoing charges figure (OCF)
2.17%

Transaction costs
0.13%

Total MiFID II charges
2.3%

P0 Acc EUR, P0 Acc CHF

Ongoing charges figure (OCF)
2.26%

Transaction costs
0.13%

Total MiFID II charges
2.39%

The MiFID II charges include the ongoing charges figure (OCF) and transaction costs. PRIIPs compliant

Factsheets
Key Investor Information

How to invest

Visit our ‘how to invest’ pages to learn about your available options to invest in the fund. This includes our distribution partners and direct postal investment.

Portfolio and market insights

Monday, June 14, 2021

Monthly market review, June 2021

Recent inflation headlines have made for uncomfortable reading, and volatility picked up as investors remained sceptical of policymakers’ messaging. But we don’t think rising inflation is here to stay as there are too many other phenomena that will push it down.

Read more

 

Thursday, December 31, 2020

Quarterly fund update, Q4 2020

The array of vaccines is definitely great for the prospects of 2021. Imagine how grim things would be if they didn’t exist … Yet we’re trying not to get carried away. There’s a long, bumpy path ahead and we have to stay alert to how our businesses are faring.

Read the full update